Taxotere - Injuries & Lawsuits

There has been a recent spike in the number of lawsuits against Taxotere maker Sanofi-Aventis over the past four weeks as additional plaintiffs come forward, attributing the permanent loss of their hair to treatment with the chemotherapy drug.As of mid-March, the number of claims stood at 799. Since...

Recently, French oncologists received a letter from that country's National Drug and Health Product Safety Agency (ANSM), informing them of five fatalities resulting from the use of Taxotere (docetaxel). As a result, the Institut Curie, France's premier cancer research and treatment center, has stopped using that chemotherapy drug and...

Drugs used in chemotherapy for cancer patients have numerous side effects, one of which is hair loss. In most cases, hair starts to grow back once the course of treatment is completed. However, for patients treated with Taxotere (docetaxel), the hair loss is often permanent.This is the cause of...

A patient who undergoes chemotherapy for the treatment of cancer can expect hair loss, among other side effects. That loss can include scalp, facial and body hair. In most cases, hair grows back approximately three to six months following the completion of treatment, but in the case of Taxotere,...

Taxotere is an unnecessary chemo drug that is adding even more suffering to women’s lives by causing alopecia (permanent hair loss). America’s Lawyer, Mike Papantonio, and attorney Ben Gordon discuss this.Transcript of Video:Papantonio: Ben, Taxotere, we’re hearing a lot about it right now, permanent baldness for thirty to forty...